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Despite recent advances in technology, a high percentage of patients with colorectal cancer present with
disease that is already advanced, leading to an overall 5-year survival rate of 49.6% in men and 50.8% in
women. In order to facilitate access to specialist cancer units, across specialities, the Department of
Health formulated the NHS Cancer Plan in 2000 which consisted, in part, of the ‘two-week rule’ (TWR).
The TWR was launched to ensure that all patients meeting speciﬁc referral criteria for suspected colo-
rectal cancer were seen by a hospital specialist within 14 days of referral. The TWR referral system was
set up with the intention of identifying 90% of patients with bowel cancer for prompt treatment.
This study was conducted to investigate the difference in presentation between patients referred via
the TWR pathway compared to those referred via an elective (non-TWR) route and to examine the
impact of these referral routes on the time to treatment and clinical outcome.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Colorectal cancer is the 3rd commonest cancer in the United
Kingdom, accounting for over 34,000 new diagnoses per annum
and 20,000 deaths per annum. Despite recent advances in tech-
nology, a high percentage of patients with colorectal cancer present
with disease that is already advanced, leading to an overall 5-year
survival rate of 49.6% in men and 50.8% in women.1 In order to
facilitate access to specialist cancer units, across specialities, the
Department of Health formulated the NHS Cancer Plan in 2000
which consisted, in part, of the ‘two-week rule’ (TWR). The TWR
was launched to ensure that all patients meeting speciﬁc referral
criteria for suspected colorectal cancer were seen by a hospital
specialist within 14 days of referral (shown in Table 1). The TWR
referral system was set up with the intention of identifying 90% of
patients with bowel cancer for prompt treatment.2
A recent study by Bevis et al. has shown that despite the
provision of the TWR, a signiﬁcant proportion of patients with
colorectal cancer is still being referred by other elective means
(non-TWR) resulting in delayed diagnosis.3 In that study, only 50%
of colorectal malignancies were referred using the TWR pathway
and 22.5% were referred via non-TWR outpatient sources.rsity Hospital Trust, Depart-
London N18 1QX, United
a Dua).
2..
ciates Ltd. Published by Elsevier LtThis study was conducted to investigate the difference in
presentation between patients referred via the TWR pathway
compared to those referred via an elective (non-TWR) route and to
examine the impact of these referral routes on the time to treat-
ment and clinical outcome.2. Methods
This study is based on our prospective database of colorectal
cancer patients, referred by their general practitioner to the North
Middlesex University Hospital, via the TWR and non-TWR path-
ways, after the introduction of the TWR proforma.When necessary,
additional data were collected retrospectively from the medical
records. Patients who presented as emergencies or were referred
by other hospital departments to the colorectal unit were excluded.
Patients were divided into two groups: those referred under the
‘two-week rule’ criteria (TWR group) and those referred electively
to the specialist clinic outside the two-week rule pathway (non-
TWR group). 75 TWR patients and 75 non-TWR patients were
matched for age and sex.
Clinical indications for referral, as listed in the TWR proforma
and/or primary care referral letter, were compared between the
two groups of patients. Operative reports were reviewed to deter-
mine the anatomical site of the malignancy.
The impact of the two referral modes on time to treatment was
analysed. Two chronological endpoints were used: ﬁrst the time
between primary care referral and specialist clinic appointment
and, second the time between primary care referral and deﬁnitived. All rights reserved.
Table 1
Department of Health’s guidelines for the referral of patients with suspected colo-
rectal cancer.
In patients of any age
 Rectal bleeding with a change in bowel habit to looser stools present for
more than 6 weeks
 A palpable right sided abdominal mass
 A palpable rectal (non-pelvic mass)
 Iron deﬁciency anaemia (haemoglobin <11 g/dL in men, <10 g/dL in
women) without obvious cause
In patients aged 60 or over
 Rectal bleeding without anal symptoms
 A change in bowel habit to looser stools or increased frequency of defae-
cation, without bleeding, persistent for 6 weeks
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the second part of the analysis.
Any potential inﬂuence of the mode of referral on disease stage,
at the time of deﬁnitive surgery, was investigated by comparing the
two groups using both the TNM and American Joint Committee on
Cancer4 classiﬁcations.
Statistical analyses were performed using the Mann–Whitney U
test, Chi-squared test and Fisher’s exact test.
3. Results
3.1. Patient demographics
150 patients were recruited into this study. 70 were female, 80
were male with a median age of 69 years (range 24–88). The
presence of co-morbid disease and ethnicity had no correlation
with referral pattern.
The anatomical distribution of cancers in the two groups is
depicted in Fig. 1. 77.3% of malignancies were in the left colon
(n¼ 116), primarily the rectum (46%, n¼ 69), compared to 20.7%
(n¼ 31) right sided colonic tumours (deﬁned as being located
proximal to the splenic ﬂexure). Patients with right sided malig-
nancies were more likely to be referred under the TWR than
patients with left sided malignancies (p¼ 0.026, Pearson Chi
Square).
3.2. Completeness of information provided
Many referral documents (both TWR and non-TWR) contained
incomplete clinical information. In this section of the study theAnatomical Distr
0
20
40
60
80
Anatom
N
u
m
b
e
r
s
Non-TWR
TWR
Fig. 1. Anatomical distribution of cancers. Number of TWR patients (red) versus number of
(p¼ 0.026, Pearson Chi Square).presenting clinical feature(s), mentioned in the referral documents,
were recorded. All positive and negative responses to each clinical
feature were noted. Where the clinical feature was not mentioned
in the referral document, it was assumed that the patient had not
been questioned about it. A total of 94 referral documents (62.6%)
indicated that the patient had been asked about change of bowel
habit, 105 patients (70%) had been questioned about rectal bleeding
and 76 patients (50.6%) had been tested for iron deﬁciency
anaemia. As shown in Table 2, information regarding change in
bowel habit (p¼ 0.0007) and iron deﬁciency anaemia (p¼ 0.0033)
was signiﬁcantly more likely to have been included in the referral
document in the TWR group compared to the non-TWR group.
There was no signiﬁcant difference between the groups on infor-
mation provided regarding rectal bleeding (Table 2).
3.3. Clinical referral criteria
Analysis of the referral documents, based on positive responses
to clinical referral criteria alone, revealed that all of the 75 patients
referred under the TWR, had met at least one of the referral criteria
listed in the NHS TWR guidelines. However, of those referred as
non-TWR, 69 (92%) would also have met at least one of the criteria
for referral under the TWR protocol.
In Table 3 the two groups are compared with respect to three
cardinal TWR referral criteria. The most common presenting
symptomwas rectal bleeding (n¼ 68 patients; 45.3%) with patients
evenly divided between the two referral groups (32 in TWR group,
36 in non-TWR group, n.s.). Accordingly, there was no signiﬁcant
difference between the two groups when using altered bowel habit
as a discriminator. Therefore, patients presenting to primary care
with rectal bleeding or change in bowel habit were equally likely to
have been referred via the TWR or non-TWR routes. The only
clinical ﬁnding that was signiﬁcantly different between the two
groups was the presence of iron deﬁciency anaemia (p¼ 0.0347).
Therefore, patients were more likely to be referred using the TWR
proforma in the presence of iron deﬁciency anaemia.
3.4. Physical examination
In 68 of 150 patients (45.3%), there was no evidence of a clinical
examination (abdominal and/or rectal) having beenperformed at all.
Evidence of a rectal examination, in the referral document, was
found in 43.3% (n¼ 65/150, 32 non-TWR, 33 TWR) in similar
number in the two groups (Table 4). In the non-TWR group, of 6ibution of Cancers
ical Region
non-TWR patients (blue). Right sided colon tumours more likely to be referred as TWR
Table 2
Inclusion of clinical information provided on referral source. Brackets indicate
percentage of cases in each group where there was demonstrated evidence of the
patient having been asked about each referral criterion.
TWR/75 Non-TWR/75 p value
Change in bowel habit 57 (76%) 37 (49.3%) 0.0007
PR bleeding 56 (74.7%) 49 (65.3%) 0.21
Iron deﬁciency anaemia 47 (62.6%) 29 (38.6%) 0.0033
Table 4
Rectal examination results. Patients underwent rectal examination in primary care
and in the colorectal clinic. The diagnoses in the referral document are listed in
column one (from left) and numbers of patients are shown in columns two and four.
The numbers of patients with rectal cancers, diagnosed in the clinic, in the two
groups are shown in columns three and ﬁve.
Diagnosis in
referral document
non-TWR TWR
Diagnosis in
primary care
Diagnosis of
rectal cancer
in clinic
Diagnosis in
primary care
Diagnosis of
rectal
cancer in
clinic
Piles 6 3 0 0
Pain 2 2 0 0
Mass 0 0 8 8
Normal 24 8 25 7
No rectal
examination
43 14 42 15
Subtotal 75 27 75 30
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on examination by the specialist. Two non-TWR patients had pain
on rectal examination and the procedure had been abandoned by
the referrer. Both of these patients were subsequently found to
have rectal tumours. All 8 patients (all in the TWR group) referred
with a palpable rectal mass were conﬁrmed to have rectal tumours
by the specialist.
Forty-nine patients were described as having had a ‘normal’
rectal examination. Of these ‘normal’ examinations, 15 were found
to have palpable rectal tumours (8 non-TWR, 7 TWR). Therefore, of
the 65 cases where rectal examination was performed in primary
care, only 28.6% of potentially palpable rectal cancers were detec-
ted (8 out of possible 15 in the TWR group and 0 out of 13 in the
non-TWR group). In the 85 patients (56.7%, 43 TWR, 42 non-TWR)
with no evidence of a rectal examination in the referral document,
29 (34.1%, 15 TWR,14 non-TWR) were found to have palpable rectal
tumours.
3.5. Impact of referral pathway on time to ﬁrst specialist clinic
appointment and treatment
The time interval between referral and specialist outpatient
clinic appointment was signiﬁcantly longer in the non-TWR group
(a mean of 57 days versus 10 days, (p< 0.0001)).
Time to treatment (as deﬁned by surgical resection), including
patients who received neoadjuvant chemoradiation, was signiﬁ-
cantly longer in patients referred as non-TWR compared to TWR
patients (161 versus 74 days, p< 0.0001, Fig. 2). In the TWR group,
13 patients received neoadjuvant chemoradiation compared to 18
in the non-TWR group (n.s). Selection of patients, with locally
advanced rectal cancer, for neoadjuvant chemoradiation was
decided by themultidisciplinary team, based onMRI staging.When
patients who received neoadjuvant chemoradiation were removed
from the analysis, mean time to treatment in TWR patients was 56
days compared to 127 days for non-TWR patients (p< 0.0001).
Palliative chemoradiation alone was given to 4 TWR patients and
none of the non-TWR.
3.6. Impact of mode of referral on cancer disease stage
The difference in referral pattern had no impact on cancer
disease stage (Fig. 3). According to the TNM classiﬁcation, mostTable 3
Criteria for referral described in referral document. Patients in the TWR and non-
TWR groups, referred according to the three cardinal clinical referral criteria. Yes -
¼ criterion positively identiﬁed, No¼ criterion recorded as not being present.
(Pearson Chi Square test).
Referral criteria TWR non-TWR p value
Iron deﬁciency anaemia Yes 34 14 0.0347
No 13 15
Change in bowel habit to loose Yes 35 19 0.33
No 22 18
Rectal bleeding Yes 32 36 0.08
No 24 13patients were T3, node negative (N0) and without metastatic
disease (M0). Further analysis was performed using the American
Committee on Cancer staging.4 As shown in Table 5, 83 patients had
stage I/II disease (T1–T4, N0, M0). This was evenly distributed
across both groups (40 TWR, 43 non-TWR). Stage III/IV disease (T1–
T4, N1–N2, M0/M1) was also very similarly distributed between the
two groups (31 TWR; 32 non-TWR). The 4 patients who underwent
palliative chemoradiation therapy only were excluded from the
analysis.4. Discussion
The Department of Health TWR pathway was designed to
expedite referral of patients meeting speciﬁc criteria to specialist
units in order to diagnose cancers at an earlier disease stage.5 This
study has shown that when patients present in primary care with
clinical features suspicious of colorectal cancer, i.e., prolonged
rectal bleeding or change in bowel habit, they are often not referred
via the TWR pathway to a specialist unit. These patients are equally
likely to be referred as routine cases. However, the presence of iron
deﬁciency anaemia prompted referral via the TWR pathway in
a signiﬁcantly higher number of cases. Therefore, an abnormal test
result enables case selection more readily than an assessment
based on clinical presentation.
All the patients in the TWR group presented with at least one
cardinal symptom that met criteria under the TWR guideline.
Clinically relevant information regarding change in bowel habit and
iron deﬁciency anaemia, but not rectal bleeding, was more likely to
be included in the referral if the TWR proformawas used. However,
in addition to the particular clinical feature that warranted referral
as a TWR, many referral forms were lacking in clinical information.
This is despite the provision of a tick-box type of proforma designed
for ease and speed of use. Therefore, a more efﬁcient use of the
TWR proforma is recommended, based on the results of this study.
This is expected to improve selection of patients for referral via the
TWR pathway.
In almost half of all cases (45.3%), there was no documented
evidence of a clinical examination (abdominal or rectal examina-
tion) by the referring clinician. In more than half of all referrals
(56.7%) there was no evidence that a digital rectal examination had
been carried out. More than one-third of these patients (34.1%),
where evidence of PR examination was lacking, had a palpable
rectal cancer detected in the specialist clinic. More worryingly,
30.6% of patients reported to have a ‘normal’ PR examination were
found to have easily palpable cancers on digital rectal examination.
Of the 57 patients identiﬁed as having palpable rectal tumours on
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Fig. 2. Time interval from referral to surgery. This data is inclusive of all patients,
including those who received neoadjuvant chemoradiation. As shown in the Results
section, when these patients were excluded from the analysis, the difference in time to
surgery, between the two groups, remains signiﬁcant. *p< 0.0001.
Table 5
Comparison of stage distribution between the TWR and non-TWR groups. Stage I
(T1/T2, N0, M0), stage II (T3/T4, N1, M0), stage III (T any, N2,M0) stage 4 (T any, N any,
M1) staging based on the American Joint Committee on Cancer, 7th edition.4
Stage TWR Non-TWR
I 14 13
II 26 30
III 22 18
IV 9 14
Unknown 4 0
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previously identiﬁed by the referring doctor. The omission of
a digital rectal examination and/or the inability to detect palpable
rectal cancers in primary care led to a failure to refer many patients
via the TWR pathway. These ﬁndings emphasize the need for
education at the primary care level to highlight the importance of
rectal examination in patients who present with colorectal
symptoms.
As expected, patients referred under the TWR guidelines were
seen in clinic signiﬁcantly faster than non-TWR patients (p< 0.05).
All TWR patients were seen within the recommended 2 weeks
(mean 10 days). By contrast, the non-TWR patients were seen after
a mean of 57 days.
The time interval between referral and deﬁnitive surgery was
also signiﬁcantly longer in non-TWR patients. The TWR patients
who did not receive neoadjuvant therapy underwent surgery
within 62 days of referral, according to the recommendations of the
cancer plan. By contrast, the mean time from referral to surgery in
the non-TWR patients was more than twice as long compared to
TWR patients (127 versus 56 days respectively)
The TWR guidelines have been adopted on the assumption that
they will lead to the diagnosis of cancer at an earlier disease stage.5Non-TWR TWR Non-TWR TWR
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Fig. 3. Colorectal cancer pathological disease stage. Comparison of cancer disease
stage between non-TWR and TWR groups. (Stage I/II and Stage III/IV, see legend in
Table 5). p¼ 0.87 (Fisher exact test).However, in this study we have not demonstrated any signiﬁcant
difference in TNM stage distribution between patients referred via
the TWR pathway and those referred routinely. Furthermore, there
was no difference in locally advanced cancers, requiring neo-
adjuvant therapy, between the TWR and non-TWR groups. There-
fore, we found no evidence that the TWR system confers any
advantage by enabling diagnosis of colorectal cancer at an earlier
disease stage, a ﬁnding supported by other investigators.6,7 There
were, however more patients with advanced cancer, suitable for
palliative treatment only, in the TWR group. This ﬁnding suggests
that patients with more aggressive disease may be more readily
selected via the TWR pathway.
5. Conclusions
A large number of patients with colorectal cancer are not
referred via the TWR pathway. The clinical presentation of these
patients does not differ from that of the patients referred via the
TWR. The possible explanation for these apparently random
referral patterns may be lack of awareness of the condition and its
common modes of presentation. The average primary care physi-
cian probably encounters one patient with colorectal cancer a year.
Therefore, our study suggests that re-education is required in the
primary care sector, in order to heighten awareness of colon and in
particular rectal cancer.
The purpose of the TWR proforma is to enable all patients with
suspected colorectal cancer to be referred urgently. Therefore, we
recommend that the TWR proforma should be employed as an aide
memoir by primary care doctors every time they encounter
a patient with colorectal symptoms. Each referral criterion, listed in
the proforma, should be enquired about and a response, positive or
negative, recorded. Any patient with one or more positive
responses should be referred via the TWR pathway.
The ﬁndings of this study suggest that the government directive
of treating all suspected cancers within 62 days of referral does not
correlate with the lag time for the progression of colorectal cancer.
The emphasis on expeditious investigation and treatment of
patients with colorectal malignancy are vital. However, this study
suggests that it may be possible to relax the strict time frames
currently recommended in the diagnosis and treatment of colo-
rectal cancer without detrimental effect on the patients, at least in
terms of the pathological stage of the disease at the time of curative
surgery. At a time when the NHS is facing challenges in demand,
capacity and investment it may be advisable to review the TWR
guidelines in colorectal cancer.
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